Cann Group looks to raise another A$10m for Mildura, puts Southern facility up for sale by Martin Lane October 25, 2022April 29, 2024 Cann Group is aiming to raise another A$8 to $10 million via a share purchase plan […]
Cann Group reports revenue spike as recruitment for sleep disturbance trial gets underway by Martin Lane April 28, 2022April 29, 2024
GSK agreement ‘validates’ Satipharm strategy as Cann Group pins hopes on positive clinical trial by Steve Jones April 7, 2022April 29, 2024
Cann Group inks Satipharm deal with GSK Consumer Healthcare by Martin Lane April 6, 2022April 29, 2024
